Save time and get answers to complex questions with AI chat
Drugpatentwatch evista historical sales market context?Is januvia still on the market?Bortezomib market france?Drugpatentwatch crizotinib?Dabrafenib patent expiration date novartis gsk composition matter?
See the DrugPatentWatch profile for cosentyx
Short answer: yes, body weight can influence how cosentyx (secukinumab) behaves in the body, and weight is a factor doctors consider when choosing the dose. What this means: - Secukinumab is available in two dose strengths (about 150 mg and 300 mg) so clinicians can tailor treatment to body weight and how severe the disease is. - In heavier people, the drug’s distribution and clearance can lead to lower drug levels with a fixed dose, which is one reason the higher dose is used for some patients. - Across weight groups, the approved dosing regimens have been shown to be effective, but heavier patients may sometimes need the 300 mg dose to achieve similar responses as lighter patients. What you should do: - If you’re concerned that your weight might affect how well cosentyx is working for you, discuss it with your doctor. They can review your response and decide whether to adjust the dose, switch dosing regimens, or consider another treatment. - Do not change your dose on your own. If you tell me your indication (plaque psoriasis, psoriatic arthritis, axial spondyloarthritis) and roughly your weight, I can summarize how dosing is typically adjusted for that situation.
Other Questions About Cosentyx :